Drugs@FDA document
DYANAVEL XR Letter · NDA 208147 SUPPL-12
Drugs@FDA document · TRIS PHARMA INC · Jun 2, 2022
Key facts
| Drug name | DYANAVEL XR |
|---|---|
| Document type | Letter |
| Application | NDA208147 |
| Submission | SUPPL-12 |
| Company | TRIS PHARMA INC |
| Document date | Jun 2, 2022 |
At a glance
- Labeling-Package Insert Document categories
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: